QuantuMDx, U of London Lead New Malaria Dx Consortium | GenomeWeb

NEW YORK (GenomeWeb News) – A new consortium has been launched in Europe with the goal of developing a handheld molecular diagnostic device to test for malaria.

The Nanomal project is led by researchers at St. George's, University College London and molecular diagnostics firm QuantuMDx and has been provided with funding of €5.2 million ($6.7 million) from the European Commission's Seventh Framework Programme. Other participants in the consortium include the University of Tuebingen in Germany and the Karolinska Institute in Sweden.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.